PNC Financial Services Group
ZOM

PNC Financial Services Group’s Zomedica Corp. ZOM Stock Holding History

PNC Financial Services Group’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-200
Closed -$32 – 4915
2022
Q4 		$32 Buy
+200
New +$41 ﹤0.01% 4734

Other funds holding ZOM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PWMG
Pinnacle Wealth Management Group Plymouth, Michigan $214M AUM 20.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

PNC Financial Services Group's ZOM Position: Q1 2023 in Review

PNC Financial Services Group sold out of Zomedica Corp. (ZOM) in Q1 2023, closing a stake of 200 shares — an estimated $32 sold.

PNC Financial Services Group first reported a position in ZOM in Q4 2022 and held it in 1 quarter. The position peaked at $32 in Q4 2022. 90 funds tracked by Wall St. Rank hold ZOM as of Q1 2023.

  • PNC Financial Services Group reported no remaining Zomedica Corp. position as of Q1 2023 after selling out during the quarter.
  • PNC Financial Services Group sold 200 Zomedica Corp. shares in Q1 2023, an estimated $32.
  • PNC Financial Services Group first reported a position in Zomedica Corp. in Q4 2022 and held it in 1 quarter.
  • PNC Financial Services Group's Zomedica Corp. position peaked at $32 in Q4 2022.
  • 90 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2023.

Based on PNC Financial Services Group's 13F filing for Q1 2023, filed 15 May 2023.